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Sophie Dahoun,4 Fre´de´rique Bena,4 Vida Cˇulic´,5 and Bojana Brajenovic´-Milic´1
The aims of the present study were to assess (1) the parental origin of trisomy 21 and the stage in which non-
disjunction occurs and (2) the relationship between altered genetic recombination and maternal age as risk factors
for trisomy 21. The study included 102 cases with Down syndrome from the Croatian population. Genotyping
analyses were performed by polymerase chain reaction using 11 short tandem repeat markers along chromosome
21q. The vast majority of trisomy 21 was of maternal origin (93%), followed by paternal (5%) and mitotic origin
(2%). The frequencies of maternal meiotic I (MI) andmeiotic II errors were 86% and 14%, respectively. The highest
proportion of cases with zero recombination was observed among those with maternal MI derived trisomy 21. A
higher proportion of telomeric exchanges were presented in cases with maternal MI errors and cases with young
mothers, although these findings were not statistically significant. The present study is the first report examining
parental origin and altered genetic recombination as a risk factor for trisomy 21 in a Croatian population. The
results support that trisomy 21 has a universal genetic etiology across different human populations.
Introduction
Trisomy 21 or Down syndrome (DS) is one of the mostcommon chromosomal abnormalities. The majority of
full trisomy 21 is caused by chromosomal nondisjunction
occurring during maternal meiotic division (*90%). Errors
occur more frequently in the first maternal meiotic division
than the second (73% vs. 25%) (Antonarakis, 1991; Antonar-
akis et al., 1992; Yoon et al., 1996; Hassold and Sherman, 2000;
Freeman et al., 2007; Ghosh et al., 2010).
In addition to the well-established effect of maternal age on
bearing a child with trisomy 21 (Hassold and Chiu, 1985;
Sherman et al., 2005; Allen et al., 2009), altered genetic recombi-
nation has also been identified as a risk factor (Lamb et al., 1996,
2005; Sherman et al., 2006). Warren et al. (1987) were the first to
report reduced levels of chromosome 21 recombination in
meioses leading to trisomy 21. Although the achiasmate biva-
lents rarely occur in normal female meiosis, about 45% of tri-
somy 21 cases are derived from maternal meiotic I (MI)
nondisjunction without recombination (Lamb et al., 1997). In
addition, the location of recombinant events influences the
ability of homologs to segregate duringmeiotic division. In cases
of maternal MI-derived trisomy 21, the majority of recombina-
tion events occurred at the telomere of 21q, whereas exchanges
occurring amongmeiotic II (MII) cases of trisomy 21 clustered at
the pericentromeric region (Lamb et al., 1997). Recently, an as-
sociation between maternal age and altered recombination was
observed in a U.S. population (Lamb et al., 2005; Oliver et al.,
2008). These studies indicated that achiasmate meiosis and sin-
gle telomeric exchange impose a risk for MI nondisjunction that
is independent of the maternal age risk. On the other hand, the
analysis of MII errors showed that the presence of a single ex-
change within the pericentromeric region of 21q is associated
with maternal age-related risk factors. A study by Ghosh et al.
(2009), on an Indian population, confirmed these results and
suggested that the genetic etiology underlying the occurrence of
trisomy 21 may be similar across human populations.
The aims of the present studywere to assess (1) the parental
origin and stage that nondisjunction occurs in trisomy 21 in a
population from Croatia, geographically located between
Central and South-eastern Europe, and (2) the relationship
between altered genetic recombination and maternal age as
risk factors for trisomy 21.
Methods
In collaboration with DS associations from larger cities in
Croatia (Rijeka, Zagreb, Pula, Zadar, Split, Karlovac,
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Cˇakovec, and Osijek), 116 blood samples were collected from
DS subjects. Both the mother and father were available in 76
cases. The blood samples only from themother were obtained
in 40 cases. All participants were of the same ethnicity (Cau-
casian). The karyotypes of the parents were confirmed as
normal. The mean ages of the mothers and fathers calculated
at the time of birth of a child with DS were 31.00– 6.5 and
34.12 – 6.8 years, respectively. All DS cases were free trisomy
21. The Ethical Committee of the School of Medicine, Uni-
versity of Rijeka, approved the study. All participants pro-
vided written informed consent prior to participation in the
genetic analysis.
DNA analysis
Genotyping analyses were performed using 11 short tan-
dem repeat (STR) markers spanning from the centromere to
the telomere of chromosome 21q. STR markers divided 21q
into three intervals. The proximal interval included the fol-
lowing markers: D21S258, D21S120, D21S1414, D21S1432,
andD21S11; themedial interval includedD21S1435, D21S226,
D21S1270, and IFNAR; and the distal interval included
D21S1412 and D21S1411 markers. Markers were selected
from the Ensembl Genome Browser database (www.ensembl
.org/index.html). The STR markers D21S120, D21S1414,
D21S1432, D21S11, D21S1435, D21S1412, and D21S1411 were
amplified one by onewith polymerase chain reaction (PCR) as
described elsewhere (Go´mez et al., 2000). PCR products were
separated by electrophoresis, which was carried out in
Spreadex gels (EL 300, 600, 800, 1200) at 55C, 120V, for 2–6 h,
depending on the size of the PCR products. Gels were stained
with Syber Green fluorescent dye and distained with appro-
priate buffer according to the manufacturer’s recommenda-
tions (Elchrom Scientific). Products were analyzed using the
digital dosage analysis software, Kodak 1D. The STRmarkers
D21S258, D21S120, D21S11, D21S1435, D21S226, D21S1270,
IFNAR, and D21S1411 were amplified together in two single-
assay quantitative fluorescent PCRs. The reaction products
were subsequently separated on an ABI 3130 genetic analyzer
and analyzed with GeneMapper software (Pavlinic´ et al.,
2008). The detection of parental origin and stage of nondis-
junction (meiotic/mitotic) and the analysis of recombination
events were done as previously described (Freeman et al.,
2007).
Statistical analysis
Statistical analyses were performed by the chi-squared test
of independence, nonparametric tests for correlations, and
simple linear regressions using Statistical software package
for Windows (2001; Stat soft, Inc.). Results were considered
statistically significant at p < 0.05.
Results
The parental origin of trisomy 21
The parental origin was successfully determined in 75 of
76 complete families and in 27 of 40 cases for which we had
samples from the mother and child only. Table 1 shows the
frequencies of the parental origin of trisomy 21 and the stage
Table 1. The Parental Origin and Stage of Nondisjunction Error Resulting in Trisomy 21
According to Parental Age
Parental origin and
stage of error
No. of
cases (%)
Percentage of
parental origin
Mean maternal
age (years – SD)
Mean paternal
age (years – SD)
Maternal 93
Meiosis I 82 (86) 31.06– 6.69 34.52– 7.11
Meiosis II 13 (14) 33.84– 4.93 35.11– 4.31
Paternal 5
Meiosis I 4 (80) 23– 5.65 25.60– 3.71
Meiosis II 1 (20) 27– 0.0 29– 0.0
Mitotic 2 2 23.50– 2.12 26– 0.0
Total cases 102
SD, standard deviation.
Table 2. The Frequency of Recombination Events Along Chromosome 21 During Maternal Meiosis
Among Mothers of Different Age Groups
No. (frequency) of subjects with:
Stage of
error
Maternal age
group
Mean maternal
age (years – SD)
Sample
size
0 observed
recombination
1 observed
recombination
2 observed
recombinations
MI Young (£ 28) 25.00– 3.65 32 25 (0.78) 6 (0.19) 1 (0.03)
Middle (29–34) 31.60– 2.07 24 19 (0.79) 4 (0.17) 1 (0.04)
Older ( ‡ 35) 37.75– 1.70 26 21 (0.80) 5 (0.20) 0
MII Young (£ 28) 28.33– 0.57 3 2 (0.66) 1 (0.33)
Middle (29–34) 32.00– 2.00 5 3 (0.60) 2 (0.40)
Older ( ‡ 35) 39.25– 3.30 5 4 (0.80) 1 (0.20)
MI, first meiotic division.
MII, second meiotic division.
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of nondisjunction according to parental age. The mean ma-
ternal age was not statistically significantly different be-
tween maternal MI- and MII-derived cases of trisomy 21
( p= 0.153).
Analysis of recombination events
Frequency of recombination and maternal age. Table 2
shows the frequencies of recombination events along chro-
mosome 21 during maternal meiosis among mothers of dif-
ferent age groups. The greatest proportion of zero
recombination (79%) was observed in the group of cases with
MI-derived trisomy 21. The frequency of this achiasmate
meiosis was not statistically significantly different among the
three different maternal age groups (young, middle, and old
age groups; p = 0.803).
Location of recombination and maternal age. Table 3
shows the location of recombination in MI- and MII-derived
trisomy 21 cases between two different maternal age groups.
Regression analysis performed on MI cases did not show a
statistically significant relationship between location of re-
combination and maternal age (t= - 1.072; p= 0.303).
Discussion
Here we present, for the first time, the parental origin of
regular trisomy 21 in a Croatian population. The vast majority
of trisomy 21 was of maternal origin (93%), followed by pa-
ternal (5%) and mitotic origin (2%). Our findings confirm the
model for DS origin found in other populations (Antonarakis,
1991; Go´mez et al., 2000; Petersen and Mikkelsen, 2000; Ma-
chatkova et al., 2005; Freeman et al., 2007; Ramı´rez et al., 2007;
Ghosh et al., 2010). The obtained frequencies of maternal MI-
derived (86%) and MII-derived (14%) trisomy 21 were dif-
ferent from the study reported by Freeman et al. (2007), but
similar to the studies on Mediterranean and Eastern Europe
populations (Go´mez et al., 2000; Machatkova et al., 2005). The
discrepancy was probably due to both the small sample size
and maternal age distribution covered by the study. As the
sample size increases, the results are more similar to that
obtained by Freeman et al. (2007), which included an im-
pressive number of cases. Allen et al. (2009) found that the
ratio of maternal MI- to MII-derived trisomy 21 cases was less
in the youngest ( < 15) and the oldest (40–50) maternal age
groups compared with that in the other maternal age groups.
For example, the MI-to-MII ratio in the 25–29 and 30–40 years
age groups were 3.5 and 4.7, respectively. Further, our study
confirmed the well-established phenomenon of advanced
maternal age as a risk factor for DS, because elevatedmaternal
age was confined to maternally derived trisomy 21 and was
associated with both maternal MI and MII errors (Antonar-
akis et al., 1992; Yoon et al., 1996; Lamb et al., 2005; Sherman
et al., 2006; Oliver et al., 2008; Allen et al., 2009).
It has been postulated that among maternal MI-derived
trisomy 21 cases, the vast majority of nondisjunction is asso-
ciated with either a lack of an exchange or a telomeric ex-
change, and that this pattern influences the risk for
nondisjunction irrespective of maternal age (Lamb et al., 2005;
Oliver et al., 2008). In contrast, among maternal MII errors
the pericentromeric exchanges were enriched among older
women and were an age-dependent factor (Oliver et al., 2008;
Ghosh et al., 2009). We also found that the highest proportion
of zero recombination occurred in cases with maternal MI-
derived trisomy 21. No statistically significant difference was
observed in the frequency of these cases among different
maternal age groups, supporting the theory of an age-
independent risk factor. Although we had a small sample for
analyzing the effect of the chiasmata position along 21q on the
susceptibility for nondisjunction, a higher proportion of
telomeric exchanges were present in cases of MI-derived tri-
somy 21 with younger mothers. The results support that tri-
somy 21 has a universal genetic etiology across different
human populations.
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